The following article provides a list of the most popular and commonly used over-the-counter drugs used to lower blood sugar levels in diabetics (and their side-effects), as compared to MicroNutra Health’s popular glucose balancing supplement, Diamaxol.
NSULIN: Lowers blood sugar levels. The various types of insulin and brands in the marketplace differ in when they take effect, when after application they’re the most effective, and the amount of time for which they’re most effective. Potential side-effects of insulin may include weight gain, low blood sugar levels, and allergic reactions.
Promoting Pancreatic Insulin Production
SULFONYLUREA: Brands include Micronase, DiaBeta, and Glucotrol. Side-effects include weight gain, low blood glucose, nausea, and rash.
MEGLITINIDE: Brands include Prandin and Starlix. Some side effects are low blood glucose and upset stomach.
Reducing Glucose Production in Liver/Aiding Insulin Processing
BIGUANIDE: Brands include Glucophage and Metformin. Side-effects include loss of appetite, nausea, gas, diarrhea, and metallic taste in mouth.
THIAZOLIDINEDIONE: Brands include Actos and Avandia. Potential side-effects include nausea/vomiting abdominal pain, fluid retention, and liver damage.
Side Effect-Free Option
Unfortunately, there are no prescription diabetes drugs without some potentially serious side-effects. This is one of the reasons that many diabetics (and pre-diabetics) find that Diamaxol is worth trying. MicroNutra claims to have clinically proven that Diamaxol has no side-effects, and they guarantee their products to be 100% effective (or your money back).
DIAMAXOL: Reduces blood sugar levels by interrupting glucose absorption within the intestines and preventing adrenal hormones from stimulating glucose production from the liver. Eliminates insulin resistance and normalizes insulin production.
Other information available on web:
1. Diabetes and Insulin - Diabetesmellitus-Information.com
2. Natural Cure for Diabetes - AyurvedicCure.com
Please share your comments below -
RSS feed for comments on this post
Leave a reply